Big COVID-19-Related Sales Drive Lilly’s Strong Q4 Performance

 
• By Joseph Haas
  
Lilly
Lilly's revenues got a big boost from bamlanivimab for COVID-19
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business